Arman Habibi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Arman Habibi has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Negin Letafatkar
Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran
4 shared publications - Ehsan Amini-Salehi
Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran
3 shared publications - Abinash Mahapatro
SIU School of Medicine, Springfield, IL, USA
2 shared publications - Fatemeh Mohammadyari
School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
2 shared publications - Maryam Jafari
Student Research Committee, School of Medicine, Anzali International Campus, Guilan University of Medical Sciences, Rasht, Iran
2 shared publications - Mohammad Amouzadeh-Lichahi
Student Research Committee, School of Medicine, Anzali International Campus, Guilan University of Medical Sciences, Rasht, Iran
2 shared publications
Latest Publications
- Open Access
- 27 October 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (11) , 7310-7319
Prevalence of metabolic syndrome among patients with multiple sclerosis: a systematic review and meta-analysis
Background: Metabolic syndrome (MetS) is a common metabolic condition that coexists with multiple sclerosis (MS), yet reported prevalence estimates vary across studies and populations. This study aims to report the prevalence of MetS among patients with MS. Methods: Observational studies reporting the prevalence of MetS among patients with MS were included. Pooled prevalence estimates were calculated using random-effects models. Results: The pooled prevalence of MetS among patients with MS was 25% (95% CI, 20–31%), with substantial heterogeneity ( I 2 = 71.87%). In subgroup analyses by MS diagnostic criteria, studies using the McDonald criteria reported a pooled prevalence of 29% (95% CI, 24–34%), and the study using International Classification of Primary Care, Second Edition (ICPC-2)/International Classification of Diseases, Ninth Revision (ICD-9) criteria reported 31% (95% CI, 25–37%). By MetS diagnostic criteria, pooled prevalence estimates were 30% (95% CI, 26–34%) using National Cholesterol Education Program Adult Treatment Panel III, 23% (95% CI, 17–31%) using International Diabetes Federation, and 16% (95% CI, 11–21%) using American Heart Association/National Heart, Lung, and Blood Institute criteria. By body mass index (BMI) category, pooled prevalence was 11% (95% CI, 2–26%) for BMI < 25, 31% (95% CI, 21–42%) for 25 ≤ BMI < 30, and 58% (95% CI, 42–73%) for BMI ≥ 30. By expanded disability status scale (EDSS) category, pooled prevalence was 28% (95% CI, 21–34%) for EDSS < 4 and 51% (95% CI, 19–83%) for EDSS ≥ 4. Conclusion: MetS is present in approximately one-quarter of patients with MS, although the precision of the estimate is limited by the small number of studies and substantial heterogeneity. Differences in study design, population characteristics, and diagnostic criteria may contribute to this variability. Further studies using standardized definitions and consistent reporting are needed to improve the comparability of prevalence estimates across settings.
- 27 October 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (11) , 7310-7319
Open AccessPrevalence of metabolic syndrome among patients with multiple sclerosis: a systematic review and meta-analysis
Background: Metabolic syndrome (MetS) is a common metabolic condition that coexists with multiple sclerosis (MS), yet reported prevalence estimates vary across studies and populations. This study aims to report the prevalence of MetS among patients with MS. Methods: Observational studies reporting the prevalence of MetS among patients with MS were included. Pooled prevalence estimates were calculated using random-effects models. Results: The pooled prevalence of MetS among patients with MS was 25% (95% CI, 20–31%), with substantial heterogeneity ( I 2 = 71.87%). In subgroup analyses by MS diagnostic criteria, studies using the McDonald criteria reported a pooled prevalence of 29% (95% CI, 24–34%), and the study using International Classification of Primary Care, Second Edition (ICPC-2)/International Classification of Diseases, Ninth Revision (ICD-9) criteria reported 31% (95% CI, 25–37%). By MetS diagnostic criteria, pooled prevalence estimates were 30% (95% CI, 26–34%) using National Cholesterol Education Program Adult Treatment Panel III, 23% (95% CI, 17–31%) using International Diabetes Federation, and 16% (95% CI, 11–21%) using American Heart Association/National Heart, Lung, and Blood Institute criteria. By body mass index (BMI) category, pooled prevalence was 11% (95% CI, 2–26%) for BMI < 25, 31% (95% CI, 21–42%) for 25 ≤ BMI < 30, and 58% (95% CI, 42–73%) for BMI ≥ 30. By expanded disability status scale (EDSS) category, pooled prevalence was 28% (95% CI, 21–34%) for EDSS < 4 and 51% (95% CI, 19–83%) for EDSS ≥ 4. Conclusion: MetS is present in approximately one-quarter of patients with MS, although the precision of the estimate is limited by the small number of studies and substantial heterogeneity. Differences in study design, population characteristics, and diagnostic criteria may contribute to this variability. Further studies using standardized definitions and consistent reporting are needed to improve the comparability of prevalence estimates across settings.
- Open Access
- 4 September 2026
- Published by Springer Nature in Egyptian Journal of Radiology and Nuclear Medicine
- Vol. 57 (1) , 183
Deep learning-based segmentation of abdominal aortic aneurysm: a systematic review and meta-analysis of performance and clinical applicability
Background: Abdominal aortic aneurysm (AAA) management relies heavily on imaging for surveillance, treatment planning, and follow-up. Deep learning (DL)-based segmentation may improve the efficiency and reproducibility of AAA image analysis; however, reported performance varies across studies. This study aimed to systematically review and quantitatively summarize the performance of DL models for AAA-related segmentation. Methods: PubMed, Embase, Scopus, and Web of Science were searched for studies applying DL to AAA imaging in adults and reporting Dice score or intersection-over-union (IoU) as segmentation metrics. Each DL model evaluated on a held-out test set was treated as a separate model-level observation. Random-effects meta-analyses were used to pool Dice score and IoU. Subgroup analyses were performed by imaging modality, model category, and input dimensionality, and additional analyses provided structure-specific estimates for aneurysm sac, intraluminal thrombus (ILT), lumen, and EVAR-related segmentations. Results: Across all targets, overall segmentation performance was 0.81 (95% CI 0.78–0.83) for Dice score and 0.72 (95% CI 0.67–0.77) for IoU. In subgroup analyses by model category, pooled Dice scores were 0.83 (95% CI 0.80–0.86) for U-Net family models, 0.82 (95% CI 0.77–0.86) for transformer or hybrid models, and 0.76 (95% CI 0.72–0.81) for other convolutional neural networks. By imaging modality, Dice scores were 0.87 (95% CI 0.84–0.89) for contrast-enhanced CT (CECT), 0.83 (95% CI 0.78–0.88) for non-contrast CT (NCCT), 0.84 (95% CI 0.81–0.87) for MRI, 0.78 (95% CI 0.74–0.82) for CT angiography (CTA), and 0.95 (95% CI 0.92–0.98) for X-ray. IoU subgroup analyses showed broadly similar patterns by modality and model category. In structure-specific analyses, aneurysm sac segmentation achieved a pooled Dice of 0.87 (95% CI 0.85–0.89) and IoU of 0.80 (95% CI 0.68–0.93); ILT segmentation reached 0.72 (95% CI 0.62–0.81) and 0.67 (95% CI 0.57–0.77); lumen segmentation 0.84 (95% CI 0.73–0.95) and 0.92 (95% CI 0.80–1.00); and EVAR-related targets 0.76 (95% CI 0.67–0.86) and 0.66 (95% CI 0.55–0.77) for Dice and IoU, respectively. Conclusions: DL-based models demonstrate good segmentation performance for the AAA sac and lumen, indicating clinically acceptable accuracy for applications such as volumetric surveillance and surgical planning. Performance for ILT and EVAR-related structures is more variable, suggesting that human oversight remains advisable for these targets in clinical practice. These findings support the use of DL-based segmentation in research and highlight its potential for selected clinical applications. However, the evidence base remains heterogeneous and is derived from a limited number of studies, with most models lacking external validation. Larger, standardized, multicentre evaluations with robust external validation are needed to confirm and refine these estimates.
- 4 September 2026
- Published by Springer Nature in Egyptian Journal of Radiology and Nuclear Medicine
- Vol. 57 (1) , 183
Open AccessDeep learning-based segmentation of abdominal aortic aneurysm: a systematic review and meta-analysis of performance and clinical applicability
Background: Abdominal aortic aneurysm (AAA) management relies heavily on imaging for surveillance, treatment planning, and follow-up. Deep learning (DL)-based segmentation may improve the efficiency and reproducibility of AAA image analysis; however, reported performance varies across studies. This study aimed to systematically review and quantitatively summarize the performance of DL models for AAA-related segmentation. Methods: PubMed, Embase, Scopus, and Web of Science were searched for studies applying DL to AAA imaging in adults and reporting Dice score or intersection-over-union (IoU) as segmentation metrics. Each DL model evaluated on a held-out test set was treated as a separate model-level observation. Random-effects meta-analyses were used to pool Dice score and IoU. Subgroup analyses were performed by imaging modality, model category, and input dimensionality, and additional analyses provided structure-specific estimates for aneurysm sac, intraluminal thrombus (ILT), lumen, and EVAR-related segmentations. Results: Across all targets, overall segmentation performance was 0.81 (95% CI 0.78–0.83) for Dice score and 0.72 (95% CI 0.67–0.77) for IoU. In subgroup analyses by model category, pooled Dice scores were 0.83 (95% CI 0.80–0.86) for U-Net family models, 0.82 (95% CI 0.77–0.86) for transformer or hybrid models, and 0.76 (95% CI 0.72–0.81) for other convolutional neural networks. By imaging modality, Dice scores were 0.87 (95% CI 0.84–0.89) for contrast-enhanced CT (CECT), 0.83 (95% CI 0.78–0.88) for non-contrast CT (NCCT), 0.84 (95% CI 0.81–0.87) for MRI, 0.78 (95% CI 0.74–0.82) for CT angiography (CTA), and 0.95 (95% CI 0.92–0.98) for X-ray. IoU subgroup analyses showed broadly similar patterns by modality and model category. In structure-specific analyses, aneurysm sac segmentation achieved a pooled Dice of 0.87 (95% CI 0.85–0.89) and IoU of 0.80 (95% CI 0.68–0.93); ILT segmentation reached 0.72 (95% CI 0.62–0.81) and 0.67 (95% CI 0.57–0.77); lumen segmentation 0.84 (95% CI 0.73–0.95) and 0.92 (95% CI 0.80–1.00); and EVAR-related targets 0.76 (95% CI 0.67–0.86) and 0.66 (95% CI 0.55–0.77) for Dice and IoU, respectively. Conclusions: DL-based models demonstrate good segmentation performance for the AAA sac and lumen, indicating clinically acceptable accuracy for applications such as volumetric surveillance and surgical planning. Performance for ILT and EVAR-related structures is more variable, suggesting that human oversight remains advisable for these targets in clinical practice. These findings support the use of DL-based segmentation in research and highlight its potential for selected clinical applications. However, the evidence base remains heterogeneous and is derived from a limited number of studies, with most models lacking external validation. Larger, standardized, multicentre evaluations with robust external validation are needed to confirm and refine these estimates.
- Open Access
- 27 February 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (9) , e47835
A unified prognostic tool for predicting critical outcomes in gastrointestinal bleeding
Gastrointestinal bleeding (GIB) is a common cause of emergency department admission and is associated with substantial morbidity and mortality. Early risk stratification remains challenging, particularly before endoscopic evaluation. This study aims to develop a novel, unified pre-endoscopic scoring system to predict early clinical deterioration in both upper and lower GIB. In this retrospective study, 403 patients with GIB admitted between 2018 and 2020 were screened, of whom 390 had complete data and were included. Clinical, laboratory, and hemodynamic parameters were extracted to derive a prognostic score predicting critical deterioration within 48 hours of admission. The primary outcome included mortality within 48 hours, intensive care unit admission, transfusion of >4 units of packed red blood cells, or need for surgery. Independent predictors identified by multivariable logistic regression were incorporated into a weighted scoring system. Discriminatory performance was assessed using the area under the receiver operating characteristic curve. Of 390 patients, 79 (20.3%) met criteria for critical deterioration. Independent predictors included age >70 years, male sex, a study-defined weighted comorbidity score ≥2, systolic blood pressure <90 mm Hg, hemoglobin < 7 g/dL, and loss of consciousness. Corresponding weighted points ranged from 2 to 4 per factor, yielding a total possible score of 0 to 17. The scoring system demonstrated excellent predictive performance (area under the receiver operating characteristic curve: 0.939), with high sensitivity and specificity across multiple cutoff points. The proposed scoring system is simple, rapid, and highly accurate for predicting early deterioration in GIB. It may serve as a practical tool for emergency department triage, early decision-making, and resource allocation. Prospective multicenter studies are warranted to validate its clinical utility.
- 27 February 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (9) , e47835
Open AccessA unified prognostic tool for predicting critical outcomes in gastrointestinal bleeding
Gastrointestinal bleeding (GIB) is a common cause of emergency department admission and is associated with substantial morbidity and mortality. Early risk stratification remains challenging, particularly before endoscopic evaluation. This study aims to develop a novel, unified pre-endoscopic scoring system to predict early clinical deterioration in both upper and lower GIB. In this retrospective study, 403 patients with GIB admitted between 2018 and 2020 were screened, of whom 390 had complete data and were included. Clinical, laboratory, and hemodynamic parameters were extracted to derive a prognostic score predicting critical deterioration within 48 hours of admission. The primary outcome included mortality within 48 hours, intensive care unit admission, transfusion of >4 units of packed red blood cells, or need for surgery. Independent predictors identified by multivariable logistic regression were incorporated into a weighted scoring system. Discriminatory performance was assessed using the area under the receiver operating characteristic curve. Of 390 patients, 79 (20.3%) met criteria for critical deterioration. Independent predictors included age >70 years, male sex, a study-defined weighted comorbidity score ≥2, systolic blood pressure <90 mm Hg, hemoglobin < 7 g/dL, and loss of consciousness. Corresponding weighted points ranged from 2 to 4 per factor, yielding a total possible score of 0 to 17. The scoring system demonstrated excellent predictive performance (area under the receiver operating characteristic curve: 0.939), with high sensitivity and specificity across multiple cutoff points. The proposed scoring system is simple, rapid, and highly accurate for predicting early deterioration in GIB. It may serve as a practical tool for emergency department triage, early decision-making, and resource allocation. Prospective multicenter studies are warranted to validate its clinical utility.
- Open Access
- 5 December 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (49) , e45885
Comprehensive evaluation of current strategies in achalasia treatment: Insights from an umbrella review
Background: Achalasia poses a considerable clinical challenge due to its complex pathophysiology and varied treatment responses. This umbrella review aims to consolidate current meta-analyses, providing a comprehensive evaluation of treatment efficacy across various methodologies. By employing statistical analyses and concise quality assessment, we seek to standardize outcomes and effectively highlight the limitations inherent in existing research. Methods: A comprehensive literature search was conducted across 5 international databases, including PubMed, Scopus, Web of Science, Embase, and the Cochrane Library, to identify relevant meta-analyses focused on achalasia treatments. Key parameters evaluated included clinical success rates, complications, operation times, and lengths of hospital stay. Statistical synthesis was employed to compare treatment effectiveness across studies. Results: The initial search identified 1037 records, of which 23 meta-analysis studies were included in this study. This review suggests that peroral endoscopic myotomy (POEM) may be comparable to, or potentially more effective than, Heller myotomy in the short-term management of achalasia. However, this was not further supported in longer follow-up durations. While POEM offers advantages such as shorter hospital stays, the ability to perform longer myotomies, and reduced operative duration, it demonstrated a greater risk of gastroesophageal reflux. However, the existing data are insufficiently conclusive, underscoring the need for additional long-term, high-quality studies to validate these results. Conclusion: This review highlights the comparable efficacy and safety of POEM and Heller myotomy in the treatment of achalasia. The variability in study quality and the presence of methodological flaws in the conducted studies underlines the need for further long-term research, improved methodological rigor, and standardized treatment protocols to optimize patient management in achalasia.
- 5 December 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (49) , e45885
Open AccessComprehensive evaluation of current strategies in achalasia treatment: Insights from an umbrella review
Background: Achalasia poses a considerable clinical challenge due to its complex pathophysiology and varied treatment responses. This umbrella review aims to consolidate current meta-analyses, providing a comprehensive evaluation of treatment efficacy across various methodologies. By employing statistical analyses and concise quality assessment, we seek to standardize outcomes and effectively highlight the limitations inherent in existing research. Methods: A comprehensive literature search was conducted across 5 international databases, including PubMed, Scopus, Web of Science, Embase, and the Cochrane Library, to identify relevant meta-analyses focused on achalasia treatments. Key parameters evaluated included clinical success rates, complications, operation times, and lengths of hospital stay. Statistical synthesis was employed to compare treatment effectiveness across studies. Results: The initial search identified 1037 records, of which 23 meta-analysis studies were included in this study. This review suggests that peroral endoscopic myotomy (POEM) may be comparable to, or potentially more effective than, Heller myotomy in the short-term management of achalasia. However, this was not further supported in longer follow-up durations. While POEM offers advantages such as shorter hospital stays, the ability to perform longer myotomies, and reduced operative duration, it demonstrated a greater risk of gastroesophageal reflux. However, the existing data are insufficiently conclusive, underscoring the need for additional long-term, high-quality studies to validate these results. Conclusion: This review highlights the comparable efficacy and safety of POEM and Heller myotomy in the treatment of achalasia. The variability in study quality and the presence of methodological flaws in the conducted studies underlines the need for further long-term research, improved methodological rigor, and standardized treatment protocols to optimize patient management in achalasia.